Search
for
Sort by
Research 91–120 of 376
- Contraception and the dermatologist
- Venous thromboembolism and women's health
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Hirsutism and virilization
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Measurement of steroid hormones by liquid chromatography-tandem mass spectrometry with small amounts of hair
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Hirsutism
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Recommendations of endocrine treatment for patients with gender dysphoria
- Pharmacological management of polycystic ovary syndrome
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Transgender and Migraine
- Obesity and female androgenic alopecia: A cause and an effect?
- Alopecia and hirsutism*
- The role of androgens in hormone replacement therapy
- Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation
- Endocrine disorders and hormonal therapy for adolescent acne
- Anti-androgen therapy in dermatology: a review
- Endocrine evaluation of hirsutism
- PCOS and Obesity: Contraception Challenges
- Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior
- New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis